David Meyronnet

689 total citations
9 papers, 370 citations indexed

About

David Meyronnet is a scholar working on Surgery, Genetics and Molecular Biology. According to data from OpenAlex, David Meyronnet has authored 9 papers receiving a total of 370 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Surgery, 3 papers in Genetics and 2 papers in Molecular Biology. Recurrent topics in David Meyronnet's work include Glioma Diagnosis and Treatment (3 papers), Infectious Diseases and Tuberculosis (2 papers) and Hedgehog Signaling Pathway Studies (2 papers). David Meyronnet is often cited by papers focused on Glioma Diagnosis and Treatment (3 papers), Infectious Diseases and Tuberculosis (2 papers) and Hedgehog Signaling Pathway Studies (2 papers). David Meyronnet collaborates with scholars based in France, Switzerland and United States. David Meyronnet's co-authors include R Loire, F. Thivolet, Lara Chalabreysse, Alain Miras, Patrice Bouvagnet, Daniel Malicier, A Tabib, Philippe Chevalier, Alain Tabib and Laurent Fanton and has published in prestigious journals such as Circulation, Blood and Journal of Neuroimmunology.

In The Last Decade

David Meyronnet

8 papers receiving 354 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Meyronnet France 6 288 107 33 33 33 9 370
Gasnat Shaboodien South Africa 11 270 0.9× 54 0.5× 77 2.3× 8 0.2× 2 0.1× 19 352
Gregory Scampardonis United States 4 320 1.1× 73 0.7× 25 0.8× 9 0.3× 1 0.0× 5 360
Shianne L. Koplitz United States 11 160 0.6× 7 0.1× 46 1.4× 3 0.1× 12 267
Alan Zunamon United States 4 115 0.4× 4 0.0× 48 1.5× 4 0.1× 6 203
Takashi Soga Japan 8 52 0.2× 2 0.0× 55 1.7× 1 0.0× 9 0.3× 25 202
Federico Navarro Sarabia Spain 7 5 0.0× 16 0.1× 8 0.2× 1 0.0× 8 0.2× 23 168
Martin Horváth Czechia 9 66 0.2× 1 0.0× 20 0.6× 1 0.0× 71 2.2× 41 244
Gerd Peters Germany 8 8 0.0× 6 0.1× 24 0.7× 21 0.6× 27 151
Devdeep Mukherjee India 8 14 0.0× 2 0.0× 32 1.0× 3 0.1× 3 0.1× 35 190
Vicente Santa‐María López Spain 7 4 0.0× 17 0.2× 19 0.6× 1 0.0× 11 0.3× 14 122

Countries citing papers authored by David Meyronnet

Since Specialization
Citations

This map shows the geographic impact of David Meyronnet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Meyronnet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Meyronnet more than expected).

Fields of papers citing papers by David Meyronnet

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Meyronnet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Meyronnet. The network helps show where David Meyronnet may publish in the future.

Co-authorship network of co-authors of David Meyronnet

This figure shows the co-authorship network connecting the top 25 collaborators of David Meyronnet. A scholar is included among the top collaborators of David Meyronnet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Meyronnet. David Meyronnet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Frappaz, Didier, Marc Barritault, Florence Laigle–Donadey, et al.. (2021). MEVITEM—a phase I/II trial of vismodegib + temozolomide vs temozolomide in patients with recurrent/refractory medulloblastoma with Sonic Hedgehog pathway activation. Neuro-Oncology. 23(11). 1949–1960. 21 indexed citations
2.
Frappaz, Didier, Marie‐Pierre Sunyach, Émilie Le Rhun, et al.. (2016). La neuro-oncologie des adolescents et adultes jeunes (AJAS) : place d’une RCP nationale. Au nom de l’ANOCEF, GO-AJA et de la SFCE. Bulletin du Cancer. 103(12). 1050–1056. 7 indexed citations
4.
Ghesquières, Hervé, Céline Ségura‐Ferlay, Gaëlle Fossard, et al.. (2015). Combination of Rituximab with Chemotherapy Improved Outcome of Newly Diagnosed Primary CNS Lymphoma: A Retrospective Study of 209 Unselected Patients Referred to a Single Institution. Blood. 126(23). 1544–1544. 1 indexed citations
5.
Charlot, Mathilde, Jean‐Baptiste Pialat, A. Boibieux, et al.. (2009). Aspergillose cérébrale : apport de l’imagerie de diffusion. Feuillets de Radiologie. 49(1). 25–31.
6.
Charlot, Mathilde, Jean‐Baptiste Pialat, A. Boibieux, et al.. (2007). Diffusion‐weighted imaging in brain aspergillosis. European Journal of Neurology. 14(8). 912–916. 25 indexed citations
7.
Camdessanché, Jean‐Philippe, François Lassablière, David Meyronnet, et al.. (2006). Expression of the onconeural CV2/CRMP5 antigen in thymus and thymoma. Journal of Neuroimmunology. 174(1-2). 168–173. 20 indexed citations
8.
Chevalier, Philippe, Alain Tabib, David Meyronnet, et al.. (2005). Quantitative study of nerves of the human left atrium. Heart Rhythm. 2(5). 518–522. 73 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026